以兹提米比
医学
瑞舒伐他汀
他汀类
内科学
危险系数
临床终点
心脏病学
物理疗法
随机对照试验
置信区间
作者
Seung‐Jun Lee,Jung‐Joon Cha,Woong Choi,Wang Soo Lee,Jin‐Ok Jeong,Seonghoon Choi,Yoon-Haeng Cho,Woo Jung Park,Jung‐Kyu Han,Yong‐Joon Lee,Sung‐Jin Hong,Chul‐Min Ahn,Byeong‐Keuk Kim,Young‐Guk Ko,Donghoon Choi,Myeong‐Ki Hong,Yangsoo Jang,Soon Jun Hong,Jung‐Sun Kim,Kyeong Ho Yun
出处
期刊：JAMA Cardiology
[American Medical Association]
日期：2023-08-02
卷期号：8 (9): 853-853
被引量：17
标识
DOI：10.1001/jamacardio.2023.2222
摘要
High-intensity statin is strongly recommended in patients at very high risk (VHR) of atherosclerotic cardiovascular disease (ASCVD). However, concerns about statin-associated adverse effects result in underuse of this strategy in practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
Stella
浮游
无极微光
BowieHuang
Criminology34
zho
Zx_1993
eric888
昏睡的蟠桃
Mic
子车茗
求助人员
Jared
AD
无情的踏歌
zik
YaRu
yznfly
彭于彦祖
nn
顺心夜南
背后的雪卉
谷雨
卷卷
皖公网安备34019202002308
